Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines-Executive summary

Rheumatology (Oxford). 2020 Apr 1;59(4):727-731. doi: 10.1093/rheumatology/kez632.
No abstract available

Keywords: Pneumocystis jirovecii; ANCA-associated vasculitis; hypogammaglobulinaemia; practise guideline; rituximab.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy*
  • Antirheumatic Agents / therapeutic use*
  • Consensus Development Conferences as Topic
  • Delphi Technique
  • Humans
  • Maintenance Chemotherapy
  • Rituximab / therapeutic use*

Substances

  • Antirheumatic Agents
  • Rituximab